C07D 241/18
Oxygen or sulfur atoms
C07D241/18 (Oxygen or sulfur atoms) appears on 394 US grants and 333 published applications in this corpus.
Search patents in C07D- Granted patents
- 394
- Published applications
- 333
- Assignees
- 218
- Inventors
- 1,420
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 4 | 0 |
| 1980 | 3 | 0 |
| 1981 | 4 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 7 | 0 |
| 1986 | 5 | 0 |
| 1987 | 8 | 0 |
| 1988 | 8 | 0 |
| 1989 | 9 | 0 |
| 1990 | 10 | 0 |
| 1991 | 11 | 0 |
| 1992 | 7 | 0 |
| 1993 | 6 | 0 |
| 1994 | 5 | 0 |
| 1995 | 12 | 0 |
| 1996 | 6 | 0 |
| 1997 | 7 | 0 |
| 1998 | 6 | 0 |
| 1999 | 12 | 0 |
| 2000 | 9 | 0 |
| 2001 | 18 | 3 |
| 2002 | 11 | 17 |
| 2003 | 10 | 18 |
| 2004 | 4 | 13 |
| 2005 | 5 | 12 |
| 2006 | 9 | 8 |
| 2007 | 8 | 11 |
| 2008 | 4 | 8 |
| 2009 | 8 | 11 |
| 2010 | 5 | 14 |
| 2011 | 9 | 9 |
| 2012 | 11 | 9 |
| 2013 | 9 | 14 |
| 2014 | 10 | 19 |
| 2015 | 11 | 14 |
| 2016 | 12 | 11 |
| 2017 | 12 | 19 |
| 2018 | 17 | 19 |
| 2019 | 10 | 16 |
| 2020 | 13 | 17 |
| 2021 | 10 | 12 |
| 2022 | 13 | 20 |
| 2023 | 5 | 13 |
| 2024 | 6 | 9 |
| 2025 | 7 | 14 |
| 2026 | 5 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- EP2 antagonist19 May 2026US 12,630,510 B2Ono Pharmaceutical Co., Ltd.
- Sigma-1 receptor ligands and therapeutic uses thereof28 Apr 2026US 12,612,371 B2Centre National De La Recherche Scientifique
- Inhibitors of SARM17 Apr 2026US 12,595,252 B2Disarm Therapeutics, Inc.
- Degraders and degrons for targeted protein degradation10 Mar 2026US 12,570,626 B2C4 Therapeutics, Inc.
- 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors3 Mar 2026US 12,565,476 B2Revolution Medicines, Inc.
- Degraders and degrons for targeted protein degradation2 Jul 2026US 2026/0184688 A1C4 Therapeutics, Inc.
- N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases11 Jun 2026US 2026/0159502 A1Step Pharma S.A.S.
- Novel compounds and uses thereof21 May 2026US 2026/0138956 A1Recursion Pharmaceuticals, Inc.
- Plant disease control method2 Oct 2025US 2025/0302041 A1Sumitomo Chemical Company, Limited
- Pyridine derivatives for treating psychiatric disorders28 Aug 2025US 2025/0270173 A1Gilgamesh Pharmaceuticals, Inc.
Most cited
By later US patents
- Benzamidine derivatives and their use as anti-coagulants92US 5,691,364 ABerlex Laboratories, Inc. · 1997
- Retroviral protease inhibiting compounds86US 5,914,332 AAbbott Laboratories · 1999
- Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof83US 6,441,172 B1Torrey Pines Institute for Molecular Studies · 2002
- Composition for treating pain79US 5,998,434 AEli Lilly and Company · 1999
- Nitrogen-containing heterocycles75US 4,834,904 AMerck Patent GmbH · 1989